In a recent study of antigen-specific CD4 and CD8 T cell responses in acute and convalescent COVID-19 patients, a substantial Th1 and TFH fraction was observed, with little Th2 or Th17 responses [83]. The gene discussed is CD4; the disease is COVID-19.